e-learning
resources
Madrid 2019
Monday, 30.09.2019
COPD and other specific entities in intensive care unit medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcomes among immunecompetent and immunocompromised and pneumonia and trachea-bronchitis in mechanical ventilation.
M. Costa deMoura (Campina Grande, Brazil), J. Moura (Campina Grande, Brazil), V. Moura (Recife, Brazil), M. Moura (Campina Grande, Brazil), R. Stirbulov (São Paulo, Brazil)
Source:
International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Session:
COPD and other specific entities in intensive care unit medicine
Session type:
Thematic Poster
Number:
2277
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Costa deMoura (Campina Grande, Brazil), J. Moura (Campina Grande, Brazil), V. Moura (Recife, Brazil), M. Moura (Campina Grande, Brazil), R. Stirbulov (São Paulo, Brazil). Outcomes among immunecompetent and immunocompromised and pneumonia and trachea-bronchitis in mechanical ventilation.. 2277
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Outcomes of noninvasive ventilation in immunosuppressed patients with acute respiratory failure due to pneumonia
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Non-invasive mechanical ventilation and mortality in immunocompromised patients hospitalized with pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Invasive mechanical ventilation in community acquired pneumonia
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Noninvasive ventilation for the immunocompromised patient with respiratory failure
Source: Annual Congress 2003 - Respiratory failure in the immunocompromised - investigation and treatment
Year: 2003
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Pneumonia in the immunocompromised patient
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=200
Year: 2006
Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Source: Eur Respir J 2002; 20: 1483-1489
Year: 2002
Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Respiratory infections in the immunocompromised host: from HIV to transplanted patient
Source: Annual Congress 2007 - Infections year in review
Year: 2007
Mortality and predictors of death in patients with pneumonia requiring mechanical ventilation
Source: Eur Respir J 2005; 26: Suppl. 49, 144s
Year: 2005
Profile of the respiratory failure in immunocompromised patients in the ICU
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Clinical application of non-invasive positive-pressure ventilation in patients with community-acquired pneumonia
Source: International Congress 2014 – Expanding the use of noninvasive ventilation in acute respiratory failure
Year: 2014
Respiratory infections in the immunocompromised host
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Factors influencing mortality in severe community acquired pneumonia requiring mechanical ventilation
Source: Eur Respir J 2006; 28: Suppl. 50, 181s
Year: 2006
Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003
Outcome of high-flow nasal cannula for acute hypoxemic respiratory failure due to pneumocystis pneumonia
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Rapid quantification of bacteria associated to ventilator associated pneumonia in endotracheal aspirate specimens
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
The outcome and predictors of mortality in patients transitioned to invasive mechanical ventilation after non-invasive ventilation failure
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept